ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Glyburide Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-23C7989
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Glyburide Market Insights Forecast to 2028
BUY CHAPTERS

Global Glyburide Market Research Report 2025

Code: QYRE-Auto-23C7989
Report
July 2025
Pages:103
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amneal Pharmaceuticals
Sanofi Aventis
Jisheng Medicine
Double Whale Pharmaceutical
Bohai Pharmaceutical
Sunlight Pharmaceutical
Shapuaisi Pharma
CR SANJIU
Physicians Total Care
Hoechst Canada
Apotex Corporation
Avanstra Inc
Dominion Pharmacal
Hikma Pharmaceuticals
Cadila Pharmaceuticals
Novartis

The global market for Glyburide was valued at US$ 1705 million in the year 2024 and is projected to reach a revised size of US$ 2516 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Glyburide Market

Glyburide Market

Glyburide is a second generation sulfonylurea used to treat patients with diabetes mellitus type II. It is typically given to patients who cannot be managed with the standard first line therapy, metformin. Glyburide stimulates insulin secretion through the closure of ATP-sensitive potassium channels on beta cells, raising intracellular potassium and calcium ion concentrations.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Glyburide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Glyburide.
The Glyburide market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Glyburide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Glyburide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Glyburide Market Report

Report Metric Details
Report Name Glyburide Market
Accounted market size in year US$ 1705 million
Forecasted market size in 2031 US$ 2516 million
CAGR 5.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 1.25mg
  • 2.5mg
  • 5mg
Segment by Application
  • Pediatric Use
  • Geriatric Use
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine, Double Whale Pharmaceutical, Bohai Pharmaceutical, Sunlight Pharmaceutical, Shapuaisi Pharma, CR Sanjiu, Physicians Total Care, Hoechst Canada, Apotex Corporation, Avanstra, Dominion Pharmacal, Hikma Pharmaceuticals, Cadila Pharmaceuticals, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Glyburide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Glyburide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Glyburide Market growing?

Ans: The Glyburide Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Glyburide Market size in 2031?

Ans: The Glyburide Market size in 2031 will be US$ 2516 million.

Who are the main players in the Glyburide Market report?

Ans: The main players in the Glyburide Market are Amneal Pharmaceuticals, Sanofi Aventis, Jisheng Medicine, Double Whale Pharmaceutical, Bohai Pharmaceutical, Sunlight Pharmaceutical, Shapuaisi Pharma, CR Sanjiu, Physicians Total Care, Hoechst Canada, Apotex Corporation, Avanstra, Dominion Pharmacal, Hikma Pharmaceuticals, Cadila Pharmaceuticals, Novartis

What are the Application segmentation covered in the Glyburide Market report?

Ans: The Applications covered in the Glyburide Market report are Pediatric Use, Geriatric Use, Others

What are the Type segmentation covered in the Glyburide Market report?

Ans: The Types covered in the Glyburide Market report are 1.25mg, 2.5mg, 5mg

Recommended Reports

Diabetes Drugs

API & Pharmaceuticals

Specialty Drug Markets

1 Glyburide Market Overview
1.1 Product Definition
1.2 Glyburide by Type
1.2.1 Global Glyburide Market Value Comparison by Type (2024 VS 2031)
1.2.2 1.25mg
1.2.3 2.5mg
1.2.4 5mg
1.3 Glyburide by Application
1.3.1 Global Glyburide Market Value by Application (2024 VS 2031)
1.3.2 Pediatric Use
1.3.3 Geriatric Use
1.3.4 Others
1.4 Global Glyburide Market Size Estimates and Forecasts
1.4.1 Global Glyburide Revenue 2020-2031
1.4.2 Global Glyburide Sales 2020-2031
1.4.3 Global Glyburide Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Glyburide Market Competition by Manufacturers
2.1 Global Glyburide Sales Market Share by Manufacturers (2020-2025)
2.2 Global Glyburide Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Glyburide Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Glyburide, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Glyburide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Glyburide, Product Type & Application
2.7 Global Key Manufacturers of Glyburide, Date of Enter into This Industry
2.8 Global Glyburide Market Competitive Situation and Trends
2.8.1 Global Glyburide Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Glyburide Players Market Share by Revenue
2.8.3 Global Glyburide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Glyburide Market Scenario by Region
3.1 Global Glyburide Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Glyburide Sales by Region: 2020-2031
3.2.1 Global Glyburide Sales by Region: 2020-2025
3.2.2 Global Glyburide Sales by Region: 2026-2031
3.3 Global Glyburide Revenue by Region: 2020-2031
3.3.1 Global Glyburide Revenue by Region: 2020-2025
3.3.2 Global Glyburide Revenue by Region: 2026-2031
3.4 North America Glyburide Market Facts & Figures by Country
3.4.1 North America Glyburide Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Glyburide Sales by Country (2020-2031)
3.4.3 North America Glyburide Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Glyburide Market Facts & Figures by Country
3.5.1 Europe Glyburide Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Glyburide Sales by Country (2020-2031)
3.5.3 Europe Glyburide Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Glyburide Market Facts & Figures by Region
3.6.1 Asia Pacific Glyburide Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Glyburide Sales by Region (2020-2031)
3.6.3 Asia Pacific Glyburide Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Glyburide Market Facts & Figures by Country
3.7.1 Latin America Glyburide Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Glyburide Sales by Country (2020-2031)
3.7.3 Latin America Glyburide Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Glyburide Market Facts & Figures by Country
3.8.1 Middle East and Africa Glyburide Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Glyburide Sales by Country (2020-2031)
3.8.3 Middle East and Africa Glyburide Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Glyburide Sales by Type (2020-2031)
4.1.1 Global Glyburide Sales by Type (2020-2025)
4.1.2 Global Glyburide Sales by Type (2026-2031)
4.1.3 Global Glyburide Sales Market Share by Type (2020-2031)
4.2 Global Glyburide Revenue by Type (2020-2031)
4.2.1 Global Glyburide Revenue by Type (2020-2025)
4.2.2 Global Glyburide Revenue by Type (2026-2031)
4.2.3 Global Glyburide Revenue Market Share by Type (2020-2031)
4.3 Global Glyburide Price by Type (2020-2031)
5 Segment by Application
5.1 Global Glyburide Sales by Application (2020-2031)
5.1.1 Global Glyburide Sales by Application (2020-2025)
5.1.2 Global Glyburide Sales by Application (2026-2031)
5.1.3 Global Glyburide Sales Market Share by Application (2020-2031)
5.2 Global Glyburide Revenue by Application (2020-2031)
5.2.1 Global Glyburide Revenue by Application (2020-2025)
5.2.2 Global Glyburide Revenue by Application (2026-2031)
5.2.3 Global Glyburide Revenue Market Share by Application (2020-2031)
5.3 Global Glyburide Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amneal Pharmaceuticals
6.1.1 Amneal Pharmaceuticals Company Information
6.1.2 Amneal Pharmaceuticals Description and Business Overview
6.1.3 Amneal Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amneal Pharmaceuticals Glyburide Product Portfolio
6.1.5 Amneal Pharmaceuticals Recent Developments/Updates
6.2 Sanofi Aventis
6.2.1 Sanofi Aventis Company Information
6.2.2 Sanofi Aventis Description and Business Overview
6.2.3 Sanofi Aventis Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Sanofi Aventis Glyburide Product Portfolio
6.2.5 Sanofi Aventis Recent Developments/Updates
6.3 Jisheng Medicine
6.3.1 Jisheng Medicine Company Information
6.3.2 Jisheng Medicine Description and Business Overview
6.3.3 Jisheng Medicine Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Jisheng Medicine Glyburide Product Portfolio
6.3.5 Jisheng Medicine Recent Developments/Updates
6.4 Double Whale Pharmaceutical
6.4.1 Double Whale Pharmaceutical Company Information
6.4.2 Double Whale Pharmaceutical Description and Business Overview
6.4.3 Double Whale Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Double Whale Pharmaceutical Glyburide Product Portfolio
6.4.5 Double Whale Pharmaceutical Recent Developments/Updates
6.5 Bohai Pharmaceutical
6.5.1 Bohai Pharmaceutical Company Information
6.5.2 Bohai Pharmaceutical Description and Business Overview
6.5.3 Bohai Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Bohai Pharmaceutical Glyburide Product Portfolio
6.5.5 Bohai Pharmaceutical Recent Developments/Updates
6.6 Sunlight Pharmaceutical
6.6.1 Sunlight Pharmaceutical Company Information
6.6.2 Sunlight Pharmaceutical Description and Business Overview
6.6.3 Sunlight Pharmaceutical Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sunlight Pharmaceutical Glyburide Product Portfolio
6.6.5 Sunlight Pharmaceutical Recent Developments/Updates
6.7 Shapuaisi Pharma
6.7.1 Shapuaisi Pharma Company Information
6.7.2 Shapuaisi Pharma Description and Business Overview
6.7.3 Shapuaisi Pharma Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Shapuaisi Pharma Glyburide Product Portfolio
6.7.5 Shapuaisi Pharma Recent Developments/Updates
6.8 CR Sanjiu
6.8.1 CR Sanjiu Company Information
6.8.2 CR Sanjiu Description and Business Overview
6.8.3 CR Sanjiu Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.8.4 CR Sanjiu Glyburide Product Portfolio
6.8.5 CR Sanjiu Recent Developments/Updates
6.9 Physicians Total Care
6.9.1 Physicians Total Care Company Information
6.9.2 Physicians Total Care Description and Business Overview
6.9.3 Physicians Total Care Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Physicians Total Care Glyburide Product Portfolio
6.9.5 Physicians Total Care Recent Developments/Updates
6.10 Hoechst Canada
6.10.1 Hoechst Canada Company Information
6.10.2 Hoechst Canada Description and Business Overview
6.10.3 Hoechst Canada Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Hoechst Canada Glyburide Product Portfolio
6.10.5 Hoechst Canada Recent Developments/Updates
6.11 Apotex Corporation
6.11.1 Apotex Corporation Company Information
6.11.2 Apotex Corporation Description and Business Overview
6.11.3 Apotex Corporation Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Apotex Corporation Glyburide Product Portfolio
6.11.5 Apotex Corporation Recent Developments/Updates
6.12 Avanstra
6.12.1 Avanstra Company Information
6.12.2 Avanstra Description and Business Overview
6.12.3 Avanstra Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Avanstra Glyburide Product Portfolio
6.12.5 Avanstra Recent Developments/Updates
6.13 Dominion Pharmacal
6.13.1 Dominion Pharmacal Company Information
6.13.2 Dominion Pharmacal Description and Business Overview
6.13.3 Dominion Pharmacal Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Dominion Pharmacal Glyburide Product Portfolio
6.13.5 Dominion Pharmacal Recent Developments/Updates
6.14 Hikma Pharmaceuticals
6.14.1 Hikma Pharmaceuticals Company Information
6.14.2 Hikma Pharmaceuticals Description and Business Overview
6.14.3 Hikma Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Hikma Pharmaceuticals Glyburide Product Portfolio
6.14.5 Hikma Pharmaceuticals Recent Developments/Updates
6.15 Cadila Pharmaceuticals
6.15.1 Cadila Pharmaceuticals Company Information
6.15.2 Cadila Pharmaceuticals Description and Business Overview
6.15.3 Cadila Pharmaceuticals Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Cadila Pharmaceuticals Glyburide Product Portfolio
6.15.5 Cadila Pharmaceuticals Recent Developments/Updates
6.16 Novartis
6.16.1 Novartis Company Information
6.16.2 Novartis Description and Business Overview
6.16.3 Novartis Glyburide Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Novartis Glyburide Product Portfolio
6.16.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Glyburide Industry Chain Analysis
7.2 Glyburide Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Glyburide Production Mode & Process Analysis
7.4 Glyburide Sales and Marketing
7.4.1 Glyburide Sales Channels
7.4.2 Glyburide Distributors
7.5 Glyburide Customer Analysis
8 Glyburide Market Dynamics
8.1 Glyburide Industry Trends
8.2 Glyburide Market Drivers
8.3 Glyburide Market Challenges
8.4 Glyburide Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amneal Pharmaceuticals
Sanofi Aventis
Jisheng Medicine
Double Whale Pharmaceutical
Bohai Pharmaceutical
Sunlight Pharmaceutical
Shapuaisi Pharma
CR SANJIU
Physicians Total Care
Hoechst Canada
Apotex Corporation
Avanstra Inc
Dominion Pharmacal
Hikma Pharmaceuticals
Cadila Pharmaceuticals
Novartis
List of Tables
 Table 1. Global Glyburide Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Glyburide Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Glyburide Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Glyburide Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Glyburide Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Glyburide Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Glyburide Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Glyburide Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Glyburide, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Glyburide, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Glyburide, Product Type & Application
 Table 12. Global Key Manufacturers of Glyburide, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Glyburide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glyburide as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Glyburide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Glyburide Sales by Region (2020-2025) & (K Units)
 Table 18. Global Glyburide Sales Market Share by Region (2020-2025)
 Table 19. Global Glyburide Sales by Region (2026-2031) & (K Units)
 Table 20. Global Glyburide Sales Market Share by Region (2026-2031)
 Table 21. Global Glyburide Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Glyburide Revenue Market Share by Region (2020-2025)
 Table 23. Global Glyburide Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Glyburide Revenue Market Share by Region (2026-2031)
 Table 25. North America Glyburide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Glyburide Sales by Country (2020-2025) & (K Units)
 Table 27. North America Glyburide Sales by Country (2026-2031) & (K Units)
 Table 28. North America Glyburide Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Glyburide Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Glyburide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Glyburide Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Glyburide Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Glyburide Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Glyburide Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Glyburide Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Glyburide Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Glyburide Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Glyburide Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Glyburide Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Glyburide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Glyburide Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Glyburide Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Glyburide Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Glyburide Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Glyburide Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Glyburide Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Glyburide Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Glyburide Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Glyburide Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Glyburide Sales (K Units) by Type (2020-2025)
 Table 51. Global Glyburide Sales (K Units) by Type (2026-2031)
 Table 52. Global Glyburide Sales Market Share by Type (2020-2025)
 Table 53. Global Glyburide Sales Market Share by Type (2026-2031)
 Table 54. Global Glyburide Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Glyburide Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Glyburide Revenue Market Share by Type (2020-2025)
 Table 57. Global Glyburide Revenue Market Share by Type (2026-2031)
 Table 58. Global Glyburide Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Glyburide Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Glyburide Sales (K Units) by Application (2020-2025)
 Table 61. Global Glyburide Sales (K Units) by Application (2026-2031)
 Table 62. Global Glyburide Sales Market Share by Application (2020-2025)
 Table 63. Global Glyburide Sales Market Share by Application (2026-2031)
 Table 64. Global Glyburide Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Glyburide Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Glyburide Revenue Market Share by Application (2020-2025)
 Table 67. Global Glyburide Revenue Market Share by Application (2026-2031)
 Table 68. Global Glyburide Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Glyburide Price (US$/Unit) by Application (2026-2031)
 Table 70. Amneal Pharmaceuticals Company Information
 Table 71. Amneal Pharmaceuticals Description and Business Overview
 Table 72. Amneal Pharmaceuticals Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Amneal Pharmaceuticals Glyburide Product
 Table 74. Amneal Pharmaceuticals Recent Developments/Updates
 Table 75. Sanofi Aventis Company Information
 Table 76. Sanofi Aventis Description and Business Overview
 Table 77. Sanofi Aventis Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Sanofi Aventis Glyburide Product
 Table 79. Sanofi Aventis Recent Developments/Updates
 Table 80. Jisheng Medicine Company Information
 Table 81. Jisheng Medicine Description and Business Overview
 Table 82. Jisheng Medicine Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Jisheng Medicine Glyburide Product
 Table 84. Jisheng Medicine Recent Developments/Updates
 Table 85. Double Whale Pharmaceutical Company Information
 Table 86. Double Whale Pharmaceutical Description and Business Overview
 Table 87. Double Whale Pharmaceutical Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Double Whale Pharmaceutical Glyburide Product
 Table 89. Double Whale Pharmaceutical Recent Developments/Updates
 Table 90. Bohai Pharmaceutical Company Information
 Table 91. Bohai Pharmaceutical Description and Business Overview
 Table 92. Bohai Pharmaceutical Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Bohai Pharmaceutical Glyburide Product
 Table 94. Bohai Pharmaceutical Recent Developments/Updates
 Table 95. Sunlight Pharmaceutical Company Information
 Table 96. Sunlight Pharmaceutical Description and Business Overview
 Table 97. Sunlight Pharmaceutical Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sunlight Pharmaceutical Glyburide Product
 Table 99. Sunlight Pharmaceutical Recent Developments/Updates
 Table 100. Shapuaisi Pharma Company Information
 Table 101. Shapuaisi Pharma Description and Business Overview
 Table 102. Shapuaisi Pharma Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Shapuaisi Pharma Glyburide Product
 Table 104. Shapuaisi Pharma Recent Developments/Updates
 Table 105. CR Sanjiu Company Information
 Table 106. CR Sanjiu Description and Business Overview
 Table 107. CR Sanjiu Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. CR Sanjiu Glyburide Product
 Table 109. CR Sanjiu Recent Developments/Updates
 Table 110. Physicians Total Care Company Information
 Table 111. Physicians Total Care Description and Business Overview
 Table 112. Physicians Total Care Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Physicians Total Care Glyburide Product
 Table 114. Physicians Total Care Recent Developments/Updates
 Table 115. Hoechst Canada Company Information
 Table 116. Hoechst Canada Description and Business Overview
 Table 117. Hoechst Canada Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Hoechst Canada Glyburide Product
 Table 119. Hoechst Canada Recent Developments/Updates
 Table 120. Apotex Corporation Company Information
 Table 121. Apotex Corporation Description and Business Overview
 Table 122. Apotex Corporation Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Apotex Corporation Glyburide Product
 Table 124. Apotex Corporation Recent Developments/Updates
 Table 125. Avanstra Company Information
 Table 126. Avanstra Description and Business Overview
 Table 127. Avanstra Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Avanstra Glyburide Product
 Table 129. Avanstra Recent Developments/Updates
 Table 130. Dominion Pharmacal Company Information
 Table 131. Dominion Pharmacal Description and Business Overview
 Table 132. Dominion Pharmacal Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Dominion Pharmacal Glyburide Product
 Table 134. Dominion Pharmacal Recent Developments/Updates
 Table 135. Hikma Pharmaceuticals Company Information
 Table 136. Hikma Pharmaceuticals Description and Business Overview
 Table 137. Hikma Pharmaceuticals Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Hikma Pharmaceuticals Glyburide Product
 Table 139. Hikma Pharmaceuticals Recent Developments/Updates
 Table 140. Cadila Pharmaceuticals Company Information
 Table 141. Cadila Pharmaceuticals Description and Business Overview
 Table 142. Cadila Pharmaceuticals Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Cadila Pharmaceuticals Glyburide Product
 Table 144. Cadila Pharmaceuticals Recent Developments/Updates
 Table 145. Novartis Company Information
 Table 146. Novartis Description and Business Overview
 Table 147. Novartis Glyburide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Novartis Glyburide Product
 Table 149. Novartis Recent Developments/Updates
 Table 150. Key Raw Materials Lists
 Table 151. Raw Materials Key Suppliers Lists
 Table 152. Glyburide Distributors List
 Table 153. Glyburide Customers List
 Table 154. Glyburide Market Trends
 Table 155. Glyburide Market Drivers
 Table 156. Glyburide Market Challenges
 Table 157. Glyburide Market Restraints
 Table 158. Research Programs/Design for This Report
 Table 159. Key Data Information from Secondary Sources
 Table 160. Key Data Information from Primary Sources
 Table 161. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Glyburide
 Figure 2. Global Glyburide Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Glyburide Market Share by Type: 2024 & 2031
 Figure 4. 1.25mg Product Picture
 Figure 5. 2.5mg Product Picture
 Figure 6. 5mg Product Picture
 Figure 7. Global Glyburide Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Glyburide Market Share by Application: 2024 & 2031
 Figure 9. Pediatric Use
 Figure 10. Geriatric Use
 Figure 11. Others
 Figure 12. Global Glyburide Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Glyburide Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Glyburide Sales (2020-2031) & (K Units)
 Figure 15. Global Glyburide Average Price (US$/Unit) & (2020-2031)
 Figure 16. Glyburide Report Years Considered
 Figure 17. Glyburide Sales Share by Manufacturers in 2024
 Figure 18. Global Glyburide Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Glyburide Players: Market Share by Revenue in Glyburide in 2024
 Figure 20. Glyburide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Glyburide Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Glyburide Sales Market Share by Country (2020-2031)
 Figure 23. North America Glyburide Revenue Market Share by Country (2020-2031)
 Figure 24. United States Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Glyburide Sales Market Share by Country (2020-2031)
 Figure 27. Europe Glyburide Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Glyburide Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Glyburide Revenue Market Share by Region (2020-2031)
 Figure 35. China Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Glyburide Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Glyburide Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Glyburide Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Glyburide Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Glyburide Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Glyburide by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Glyburide by Type (2020-2031)
 Figure 56. Global Glyburide Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Glyburide by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Glyburide by Application (2020-2031)
 Figure 59. Global Glyburide Price (US$/Unit) by Application (2020-2031)
 Figure 60. Glyburide Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Global Glyburide and Metformin Hydrochloride Market Research Report 2025
Global Metformin Hydrochloride and Glibenclamide Tablets Market Research Report 2025
Global Type 2 Diabetes Medications Market Research Report 2024
Glyburide API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
GLP Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Metformin Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antidiabetic Agents Market Insights Forecast to 2030
Global Liraglutide for The Treatment of Diabetes and Obesity Market Research Report 2024
Metformin Hydrochloride Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glibenclamide API Market Research Report 2025
Diabetes Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Meglinitide Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gliclazide Reagent Market Research Report 2024
Global Glimepiride API Market Research Report 2024
Global Nateglinide Market Research Report 2024
Exenatide Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025
Type 2 Diabetes Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Metformin Hydrochloride Tablet Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Gliclazide Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions